NSE · MOREPENLAB
Morepen Laboratories Limited (MOREPENLAB) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#825
of 5,047 stocks
▼ 91W▼ 1081M
Peak #683 · 02 Oct 2026
A midcap name in Healthcare, Morepen Laboratories Limited carries a steep earnings multiple that prices in strong future growth, is seeing revenue slip, and posts a modest return on equity.
Market Cap
5,186.62 Cr
P/E Ratio
54.72
P/B Ratio
4.16
ROE
7.61%
ROCE
7.64%
Dividend Yield
0.21%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 746.50 Cr | 570.13 Cr | 484.72 Cr | 484.16 Cr |
| Net Profit | 88.89 Cr | 56.40 Cr | 15.74 Cr | 27.51 Cr |
| EPS | 1.62 | 1.03 | 0.28 | 0.50 |
| Operating Profit | 121.73 Cr | 79.37 Cr | 27.16 Cr | 39.74 Cr |
Shareholding pattern
Promoter
35.65%
Public
64.35%
PUBLIC BREAKDOWN
FII
1.46%
DII
1.28%
MF (within DII)
0.00%
Individuals
50.97%
Mutual fund holdings
₹0.20
Cr total
5
Schemes
3
Fund Houses
₹0.20 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.12 Cr (61.2%)
Bandhan Mutual Fund₹0.05 Cr (26.5%)
Aditya Birla Sun Life Mutual Fund₹0.02 Cr (12.4%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 18 Sep 2026 | Dividend | Dividend - Re 0.20 Per Share |
| 29 Aug 2025 | Dividend | Dividend - Re 0.20 Per Share |
| 20 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 19 Sep 2022 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.